Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Transition Therapeutics Inc

+ Add to Watchlist


6.9200 USD 0.0700 1.02%

As of 20:10:00 ET on 05/21/2015.

Company Profile for Transition Therapeutics Inc (TTHI)

Transition Therapeutics Inc. is a biopharmaceutical company focused on developing novel therapeutics in order to address global medical needs in large disease indications, including Alzheimer's disease and diabetes.

Contact Information

Transition Therapeutics Inc

101 College Street
Suite 220
Toronto, ON M5G 1L7
Phone: 1-416-260-7770
Fax: 1-416-260-2886

Key Executives for Transition Therapeutics Inc (TTHI)

Tony F CruzChairman/CEONicole Rusaw GeorgeChief Financial Officer
Carl DamianiChief Operating OfficerAleksandra PastrakVP:Clinical Dev/Medical Ofcr
Bruce ConnopVP:Non-Clinical & Pharma DevLouis AlexopoulosSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil